神经科

订阅

MedSci主页 / 所有栏目 / 神经科

关于举办第十二届全国言语障碍、吞咽困难、暨脑血管病规范化治疗培训班的通知

2016-02-23 河北燕达医院 MedSci原创

第十二届言语障碍吞咽困难血管病培训
关注

国家继续医学教育项目 关于举办第十二届全国言语障碍、吞咽困难、暨脑血管病规范化治疗培训班的通知 活动时间：2月26-28日 活动地点：河北燕达医院 媒体支持：梅斯医学（MedSci） 活动介绍         首都医科大学附属北京天坛医院神经内科已成功举办过十一期言语障碍、吞咽困难培训班，参加



国家继续医学教育项目
关于举办第十二届全国言语障碍、吞咽困难、暨脑血管病规范化治疗培训班的通知

活动时间：2月26-28日
活动地点：河北燕达医院
媒体支持：梅斯医学（MedSci）

活动介绍        

首都医科大学附属北京天坛医院神经内科已成功举办过十一期言语障碍、吞咽困难培训班，参加的学员从第一期的20多人，发展到第十一期的400多人，培训班每年都会依据学员的水平，学术发展的新技术、新方法，更新授课内容。

为继续满足各单位培训康复人才的需要，北京天坛医院神经内科将联合河北燕达医院于2016年2月26-28日举办第十二届为期3天的言语障碍、吞咽困难，脑血管病规范化治疗培训班。
培训内容        本培训班将由北京天坛医院、中国康复研究中心、中日友好医院、北京师范大学、上海中医药大学、安徽医科大学等单位从事言语障碍、吞咽困难，脑血管病规范化治疗的专家讲授相关的内容。

培训班注重理论与实践相结合，主要教授言语障碍、吞咽困难，脑血管病的评价与治疗，并针对具体病人，示范训练方法。本培训班为全国继续医学教育项目，培训结束后，授予国家级继续教育学分10分，项目编号2016-03-07-059(国)。

教学目的：学习言语障碍、吞咽困难，脑血管病治疗的理论与训练技术，重在学员的实际治疗能力的提高。

教学方法：理论教学、示范、实习、讨论相结合。

收费标准：学费1000元（包括资料费和授课示范光盘5套），食宿由培训班统一安排，费用由河北燕达医院负责。

报到授课地点：北京东燕郊开发区（河北三河燕郊开发区）燕达国际健康城内（报到时间：2016年2月25日早8:00－20:00）

联系人:孙珊珊：15100695806；郑晨阳：15832606162

联系邮箱：690295211@qq.com; 776265437@qq.com



授课专家



王拥军
首都医科大学附属北京天坛医院副院长 主任医师 教授
授课题目：《脑血管病的精准医学》


赵性泉
首都医科大学附属北京天坛医院神经内科常务副主任 党支部书记 医学博士 主任医师 教授
授课题目：《2015年脑血管病的研究进展》


汪凯
安徽医科大学第一附属医院神经内科主任 安徽省神经病学会主任委员 主任医师 教授 博士 博士生导师
授课题目：《额颞叶痴呆》

\

杨中华
北京天坛医院神经内科党支部副书记 脑血管病中心一病区副主任
授课题目：《卒中相关性肺炎》


王春雪
首都医科大学附属北京天坛医院神经内科主任医师 教授 神经精神医学科主任
授课题目：《缺血性卒中二级预防新进展》


谢欲晓
中日友好医院康复医学科主任医师 教授 硕士生导师
授课题目：《认知功能障碍的评定与康复》 《失语症的康复训练》


单春雷
上海中医药大学康复医学院副院长 教授 主任医师 博士生导师 博士
授课题目：《镜像神经元》 《失读症》


恽晓平
中国康复研究中心北京博爱医院康复评定科主任
授课题目：《失算症的评估与康复》

汪洁
首都医科大学宣武医院康复医学科副主任治疗师 中国康复医学会理事 中国康复医学会康复治疗学会常务委员
授课题目：《汉语失语症心理语言评价》

韩在柱
北京师范大学脑与认知科学研究院教授 博士生导师 副院长
授课题目：《失语症的语言学基础》


卫冬洁
中国康复研究中心北京博爱医院 听力语言治疗科 副主任治疗师
授课题目：《构音障碍的评定与康复》

张婧
首都医科大学附属北京天坛医院神经重症医学科副主任医师
授课题目：《吞咽困难的研究进展》


张玉梅
首都医科大学附属北京天坛医院神经内科主任医师 博士研究生导师
授课题目：《失语症的临床特征》 《血管性认知功能障碍》 《认知功能障碍的影像学评价》


 薛勇
中日友好医院康复科言语治疗负责人 主管治疗师 微信平台“话语泉”创始人
授课题目：《吞咽困难的评价与康复》


交通方式

乘坐北京地铁1号线在国贸或大望路站下，乘坐811\812\815\816\817\930路等任意一班公交车抵达燕郊后，在燕郊兴达广场小区（进入燕郊第一站）下车，南行300米过铁道桥步行即至燕达国际健康城内的燕达国宾大酒店。


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1691316, encodeId=068f16913163b, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Tue Dec 06 15:41:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803731, encodeId=8c411803e31b5, content=<a href='/topic/show?id=9bace58693f' target=_blank style='color:#2F92EE;'>#第十二届#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75869, encryptionId=9bace58693f, topicName=第十二届)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sun May 29 22:41:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644467, encodeId=251f164446e5f, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 02 04:41:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318594, encodeId=bd06131859432, content=<a href='/topic/show?id=25eb391692f' target=_blank style='color:#2F92EE;'>#吞咽困难#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39169, encryptionId=25eb391692f, topicName=吞咽困难)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Feb 25 04:41:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65417, encodeId=3d5a6541e9e, content=应该好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Feb 24 16:58:00 CST 2016, time=2016-02-24, status=1, ipAttribution=)]
    2016-12-06 windight

    #规范化#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1691316, encodeId=068f16913163b, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Tue Dec 06 15:41:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803731, encodeId=8c411803e31b5, content=<a href='/topic/show?id=9bace58693f' target=_blank style='color:#2F92EE;'>#第十二届#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75869, encryptionId=9bace58693f, topicName=第十二届)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sun May 29 22:41:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644467, encodeId=251f164446e5f, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 02 04:41:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318594, encodeId=bd06131859432, content=<a href='/topic/show?id=25eb391692f' target=_blank style='color:#2F92EE;'>#吞咽困难#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39169, encryptionId=25eb391692f, topicName=吞咽困难)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Feb 25 04:41:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65417, encodeId=3d5a6541e9e, content=应该好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Feb 24 16:58:00 CST 2016, time=2016-02-24, status=1, ipAttribution=)]
    2016-05-29 12498da4m32(暂无昵称)

    #第十二届#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1691316, encodeId=068f16913163b, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Tue Dec 06 15:41:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803731, encodeId=8c411803e31b5, content=<a href='/topic/show?id=9bace58693f' target=_blank style='color:#2F92EE;'>#第十二届#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75869, encryptionId=9bace58693f, topicName=第十二届)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sun May 29 22:41:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644467, encodeId=251f164446e5f, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 02 04:41:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318594, encodeId=bd06131859432, content=<a href='/topic/show?id=25eb391692f' target=_blank style='color:#2F92EE;'>#吞咽困难#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39169, encryptionId=25eb391692f, topicName=吞咽困难)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Feb 25 04:41:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65417, encodeId=3d5a6541e9e, content=应该好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Feb 24 16:58:00 CST 2016, time=2016-02-24, status=1, ipAttribution=)]
    2016-09-02 Luyuxie_17

    #血管病#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1691316, encodeId=068f16913163b, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Tue Dec 06 15:41:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803731, encodeId=8c411803e31b5, content=<a href='/topic/show?id=9bace58693f' target=_blank style='color:#2F92EE;'>#第十二届#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75869, encryptionId=9bace58693f, topicName=第十二届)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sun May 29 22:41:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644467, encodeId=251f164446e5f, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 02 04:41:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318594, encodeId=bd06131859432, content=<a href='/topic/show?id=25eb391692f' target=_blank style='color:#2F92EE;'>#吞咽困难#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39169, encryptionId=25eb391692f, topicName=吞咽困难)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Feb 25 04:41:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65417, encodeId=3d5a6541e9e, content=应该好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Feb 24 16:58:00 CST 2016, time=2016-02-24, status=1, ipAttribution=)]
    2016-02-25 智智灵药

    #吞咽困难#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1691316, encodeId=068f16913163b, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Tue Dec 06 15:41:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803731, encodeId=8c411803e31b5, content=<a href='/topic/show?id=9bace58693f' target=_blank style='color:#2F92EE;'>#第十二届#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75869, encryptionId=9bace58693f, topicName=第十二届)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sun May 29 22:41:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644467, encodeId=251f164446e5f, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Fri Sep 02 04:41:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318594, encodeId=bd06131859432, content=<a href='/topic/show?id=25eb391692f' target=_blank style='color:#2F92EE;'>#吞咽困难#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39169, encryptionId=25eb391692f, topicName=吞咽困难)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Feb 25 04:41:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65417, encodeId=3d5a6541e9e, content=应该好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Feb 24 16:58:00 CST 2016, time=2016-02-24, status=1, ipAttribution=)]
    2016-02-24 老段

    应该好好学习

    0